State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
Advanced Solid Tumor (6)Advanced Solid Tumors (5)Glioma (4)Multiple Myeloma (4)Metastatic Breast Cancer (4)Parkinson Disease (4)Stage IVB Prostate Cancer AJCC v8 (4)Breast Cancer (4)Chronic Lymphocytic Leukemia (4)Prostate Cancer (4)Non-Small Cell Lung Cancer (3)Head and Neck Squamous Cell Carcinoma (3)
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 345 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 345. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Advanced Solid Tumors, Glioma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT01904188 N/A
Recruiting
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting ...
Condition
Sepsis
Enrollment
2,500 pts
Location
United States
Sponsor
Michigan State University
NCT05005403 Phase 1
Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With N...
Condition
Non-Small Cell Lung Cancer
Enrollment
694 pts
Location
United States, Canada, Israel
Sponsor
AbbVie
NCT04458688 N/A
Recruiting
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With...
Condition
Multiple Sclerosis, Relapsing-Remitting
Enrollment
80 pts
Location
United States
Sponsor
Wayne State University
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
NCT03850366 Phase 2
Recruiting
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transpla...
Condition
Hematological Malignancy
Enrollment
15 pts
Location
United States
Sponsor
Henry Ford Health System
NCT06517875 Phase 2
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Trans...
Condition
Primary Myelofibrosis
Enrollment
68 pts
Location
United States, Canada, France
Sponsor
GlaxoSmithKline
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
NCT07359846 Phase 3
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With...
Condition
Severe Asthma
Enrollment
786 pts
Location
United States
Sponsor
Generate Biomedicines
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT05000645 N/A
Recruiting
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
Condition
Pregnancy
Enrollment
570 pts
Location
United States
Sponsor
University of Michigan
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT07515664 Phase 4
Recruiting
Vitamin K for Perioperative Warfarin Management
Condition
Anticoagulant Therapy
Enrollment
20 pts
Location
United States
Sponsor
University of Michigan
NCT05686798 Phase 1
Recruiting
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astroc...
Condition
Malignant Glioma of Brain
Enrollment
18 pts
Location
United States
Sponsor
Henry Ford Health System
NCT05201781 Phase 4
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autole...
Condition
Multiple Myeloma
Enrollment
295 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT05594563 Phase 2
Recruiting
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
Condition
Type 1 Diabetes
Enrollment
81 pts
Location
United States
Sponsor
Emily K. Sims
NCT06516952 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant...
Condition
Prurigo Nodularis
Enrollment
330 pts
Location
United States, Argentina, Austria
Sponsor
Incyte Corporation
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
NCT05787821 N/A
Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Condition
Knee Pain Chronic
Enrollment
760 pts
Location
United States
Sponsor
Zimmer Biomet
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
210 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT06155643 N/A
Recruiting
EKO SENSORA: Detecting Clinically Significant Murmurs
Condition
Heart Murmurs
Enrollment
300 pts
Location
United States
Sponsor
Corewell Health South
NCT07204340 Phase 1
Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
Condition
KRAS Mutant Solid Tumors
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Treeline Biosciences, Inc.
Page 1 of 14 — 345 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology